Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 968

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification

Open access
Weng, Hengyou, Huang, Huilin, Wu, Huizhe, Qin, Xi, Zhao, Boxuan Simen, Dong, Lei, Shi, Hailing, Skibbe, Jennifer, Shen, Chao, Hu, Chao, Sheng, Yue, Wang, Yungui, Wunderlich, Mark, Zhang, Bin, Dore, Louis C., Su, Rui, Deng, Xiaolan, Ferchen, Kyle, Li, Chenying, Sun, Miao, Lu, Zhike, Jiang, Xi, Marcucci, Guido, Mulloy, James C., Yang, Jianhua, Qian, Zhijian, Wei, Minjie, He, Chuan, Chen, Jianjun·2018·Cell Stem Cell

Abstract

SUMMARY N6-methyladenosine (m6A), the most prevalent internal modification in eukaryotic messenger RNAs (mRNAs), plays critical roles in many bioprocesses. However, its functions in normal and malignant hematopoiesis remain elusive. Here we report METTL14, a key component of the m6A methyltransferase complex, is highly expressed in normal hematopoietic stem/progenitor cells (HSPCs) and acute myeloid leukemia (AML) cells carrying t(11q23), t(15;17), or t(8;21), and is down-regulated during myeloid differentiation. Silencing of METTL14 promotes terminal myeloid differentiation of normal HSPCs and AML cells, and inhibits AML cell survival/proliferation. METTL14 is required for development/maintenance of AML and self-renewal of leukemia stem/initiation cells (LSCs/LICs). Mechanistically, METTL14 exerts its oncogenic role by regulating its mRNA targets (e.g., MYB and MYC) through m6A modification, while itself is negatively regulated by SPI1. Collectively, our results reveal the SPI1⊣METTL14-MYB/MYC signaling axis in myelopoiesis and leukemogenesis, and highlight the critical roles of METTL14 and m6A modification in normal and malignant hematopoiesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2017.11.016

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 968

Metadata

Authors
Weng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., Shi, H., Skibbe, J., Shen, C., Hu, C., Sheng, Y., Wang, Y., Wunderlich, M., Zhang, B., Dore, L. C., Su, R., Deng, X., Ferchen, K., Li, C., Sun, M., Lu, Z., Jiang, X., Marcucci, G., Mulloy, J. C., Yang, J., Qian, Z., Wei, M., He, C., & Chen, J.
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2018-02
Volume
22
Issue
2
Pages
191-205.e9
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W2776540408
Cited by
968
References
16
FWCI
25.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. https://app.cochat.ai/papers/10.1016/j.stem.2017.11.016
The paper
Weng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., Shi, H., Skibbe, J., Shen, C., Hu, C., Sheng, Y., Wang, Y., Wunderlich, M., Zhang, B., Dore, L. C., Su, R., Deng, X., Ferchen, K., Li, C., . . . Chen, J. (2018). METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. Cell Stem Cell. https://doi.org/10.1016/j.stem.2017.11.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.